Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis. NPJ breast cancer Huang, S. Y., Franc, B. L., Harnish, R. J., Liu, G., Mitra, D., Copeland, T. P., Arasu, V. A., Kornak, J., Jones, E. F., Behr, S. C., Hylton, N. M., Price, E. R., Esserman, L., Seo, Y. 2018; 4: 24


Radiomics is an emerging technology for imaging biomarker discovery and disease-specific personalized treatment management. This paper aims to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization breast cancer phenotype and prognosis. Eighty-four features were extracted from PET and MR images of 113 breast cancer patients. Unsupervised clustering based on PET and MRI radiomic features created three subgroups. These derived subgroups were statistically significantly associated with tumor grade (p?=?2.0?×?10-6), tumor overall stage (p?=?0.037), breast cancer subtypes (p?=?0.0085), and disease recurrence status (p?=?0.0053). The PET-derived first-order statistics and gray level co-occurrence matrix (GLCM) textural features were discriminative of breast cancer tumor grade, which was confirmed by the results of L2-regularization logistic regression (with repeated nested cross-validation) with an estimated area under the receiver operating characteristic curve (AUC) of 0.76 (95% confidence interval (CI)?=?[0.62, 0.83]). The results of ElasticNet logistic regression indicated that PET and MR radiomics distinguished recurrence-free survival, with a mean AUC of 0.75 (95% CI?=?[0.62, 0.88]) and 0.68 (95% CI?=?[0.58, 0.81]) for 1 and 2 years, respectively. The MRI-derived GLCM inverse difference moment normalized (IDMN) and the PET-derived GLCM cluster prominence were among the key features in the predictive models for recurrence-free survival. In conclusion, radiomic features from PET and MR images could be helpful in deciphering breast cancer phenotypes and may have potential as imaging biomarkers for prediction of breast cancer recurrence-free survival.

View details for DOI 10.1038/s41523-018-0078-2

View details for PubMedID 30131973

View details for PubMedCentralID PMC6095872